Q1 2025 · 13F-HR
Alphabet Inc. (GOOG, GOOGL)holdings as filed
Filed 2025-05-02 · accession 0001652044-25-000045
$1.58B
Reported value
40
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 358054104 | FRSH | FRESHWORKS INC | $228.7M | 14.5% | 16,206,643 | Common | SHARED |
| 042068205 | ARM | ARM HOLDINGS PLC | $209.4M | 13.3% | 1,960,784 | Common | SHARED |
| 00217D100 | ASTS | AST SPACEMOBILE INC | $203.4M | 12.9% | 8,943,486 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $146.2M | 9.27% | 4,133,277 | Common | SHARED |
| 59267L107 | — | METSERA INC | $135.1M | 8.56% | 4,961,744 | Common | SHARED |
| 37637K108 | GTLB | GITLAB INC | $128.1M | 8.12% | 2,724,712 | Common | SHARED |
| 72703X106 | PL | PLANET LABS PBC | $108.0M | 6.85% | 31,942,641 | Common | SHARED |
| 88023B103 | TEM | TEMPUS AI INC | $74.8M | 4.74% | 1,551,102 | Common | SHARED |
| 90364P105 | PATH | UIPATH INC | $72.5M | 4.59% | 7,034,337 | Common | SHARED |
| 252131107 | DXCM | DEXCOM INC | $70.8M | 4.49% | 1,036,937 | Common | SHARED |
| 92539P101 | — | VERVE THERAPEUTICS INC | $56.4M | 3.58% | 12,349,086 | Common | SHARED |
| 74168J101 | PRME | PRIME MEDICINE INC | $30.0M | 1.90% | 15,062,498 | Common | SHARED |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $26.6M | 1.68% | 2,412,471 | Common | SHARED |
| 22788C105 | CRWD | CROWDSTRIKE HLDGS INC | $26.2M | 1.66% | 74,230 | Common | SHARED |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $6.8M | 0.43% | 1,464,015 | Common | SHARED |
| 687793109 | OSCR | OSCAR HEALTH INC | $6.3M | 0.40% | 481,988 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $6.3M | 0.40% | 321,604 | Common | SHARED |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $5.8M | 0.37% | 241,264 | Common | SHARED |
| 25058X303 | DM* | DESKTOP METAL INC | $5.4M | 0.34% | 1,104,871 | Common | SHARED |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $4.7M | 0.30% | 2,812,500 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $4.1M | 0.26% | 1,568,753 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $3.8M | 0.24% | 208,697 | Common | SHARED |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $3.2M | 0.20% | 5,865,125 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $2.0M | 0.13% | 22,711 | Common | SHARED |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.8M | 0.12% | 500,901 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $1.5M | 0.09% | 1,077,080 | Common | SHARED |
| 91864C107 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $1.5M | 0.09% | 1,513,644 | Common | SHARED |
| 50107A104 | KRON1USD | KRONOS BIO INC | $1.2M | 0.08% | 1,438,232 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.1M | 0.07% | 698,262 | Common | SHARED |
| 30063P105 | EXK | EXACT SCIENCES CORP | $1.0M | 0.06% | 23,205 | Common | SHARED |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $890,826 | 0.06% | 640,882 | Common | SHARED |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $788,475 | 0.05% | 662,584 | Common | SHARED |
| 44916K106 | HYPR | HYPERFINE INC | $647,078 | 0.04% | 898,720 | Common | SHARED |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $640,785 | 0.04% | 889,979 | Common | SHARED |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $565,100 | 0.04% | 448,492 | Common | SHARED |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $521,952 | 0.03% | 915,705 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $251,532 | 0.02% | 189,122 | Common | SHARED |
| 014442107 | ALEC | ALECTOR INC | $216,315 | 0.01% | 175,866 | Common | SHARED |
| 759916109 | RGEN | REPLIGEN CORP | $48,733 | 0.00% | 383 | Common | SHARED |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $41,075 | 0.00% | 14,262 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.